Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

LUSIGNAN

Showing results (541-550 of 628) with videos related to

Pageof 63
Sort By:
Scientific Reports|November 7, 2025
Comparative risk of end-stage renal disease, myocardial infarction and stroke in young and older onset diabetes in UK BiobankDebasish Kar, Mariam Molokhia, Anthony Wierzbicki, et al.
The Journal of Infection|May 18, 2021
The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort studyAzmaeen Zarif, Mark Joy, Julian Sherlock, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 9, 2017
End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17Richard Pebody, Fiona Warburton, Joanna Ellis, et al.
Trials|February 14, 2026
Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): protocol for a primary care based, open-label, randomised controlled non-inferiority trialMelanie Carr, Nicola Kenealy, Ly-Mee Yu, et al.
International Journal of Epidemiology|October 22, 2022
Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and WalesSteven Kerr, Stuart Bedston, Declan T Bradley, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 14, 2016
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season resultsRichard Pebody, Fiona Warburton, Joanna Ellis, et al.
Drug Safety|January 19, 2021
Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE ProjectCorinne Willame, Caitlin Dodd, Lieke van der Aa, et al.
Frontiers in Psychiatry|August 12, 2022
Investigating the links between diagnostic uncertainty, emotional exhaustion, and turnover intention in General Practitioners working in the United KingdomAnli Yue Zhou, Salwa S Zghebi, Alexander Hodkinson, et al.
Nature Communications|August 15, 2022
Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in ScotlandColin R Simpson, Steven Kerr, Srinivasa Vittal Katikireddi, et al.
The Lancet Regional Health. Europe|September 6, 2023
Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohortMark Joy, Utkarsh Agrawal, Xuejuan Fan, et al.
Pageof 63

Showing results (541-550 of 628) with videos related to

Sort By:
Pageof 63
Scientific Reports|November 7, 2025
Comparative risk of end-stage renal disease, myocardial infarction and stroke in young and older onset diabetes in UK BiobankDebasish Kar, Mariam Molokhia, Anthony Wierzbicki, et al.
The Journal of Infection|May 18, 2021
The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort studyAzmaeen Zarif, Mark Joy, Julian Sherlock, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 9, 2017
End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17Richard Pebody, Fiona Warburton, Joanna Ellis, et al.
Trials|February 14, 2026
Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): protocol for a primary care based, open-label, randomised controlled non-inferiority trialMelanie Carr, Nicola Kenealy, Ly-Mee Yu, et al.
International Journal of Epidemiology|October 22, 2022
Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and WalesSteven Kerr, Stuart Bedston, Declan T Bradley, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 14, 2016
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season resultsRichard Pebody, Fiona Warburton, Joanna Ellis, et al.
Drug Safety|January 19, 2021
Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE ProjectCorinne Willame, Caitlin Dodd, Lieke van der Aa, et al.
Frontiers in Psychiatry|August 12, 2022
Investigating the links between diagnostic uncertainty, emotional exhaustion, and turnover intention in General Practitioners working in the United KingdomAnli Yue Zhou, Salwa S Zghebi, Alexander Hodkinson, et al.
Nature Communications|August 15, 2022
Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in ScotlandColin R Simpson, Steven Kerr, Srinivasa Vittal Katikireddi, et al.
The Lancet Regional Health. Europe|September 6, 2023
Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohortMark Joy, Utkarsh Agrawal, Xuejuan Fan, et al.
Pageof 63